Literature DB >> 11896166

Depletion of cholinergic amacrine cells by a novel immunotoxin does not perturb the formation of segregated on and off cone bipolar cell projections.

Emine Gunhan1, Prabhakara V Choudary, Thomas E Landerholm, Leo M Chalupa.   

Abstract

Cone bipolar cells are the first retinal neurons that respond in a differential manner to light onset and offset. In the mature retina, the terminal arbors of On and Off cone bipolar cells terminate in different sublaminas of the inner plexiform layer (IPL) where they form synapses with the dendrites of On and Off retinal ganglion cells and with the stratified processes of cholinergic amacrine cells. Here we first show that cholinergic processes within the On and Off sublaminas of the IPL are present early in development, being evident in the rat on the day of birth, approximately 10 d before the formation of segregated cone bipolar cell axons. This temporal sequence, as well as our previous finding that the segregation of On and Off cone bipolar cell inputs occurs in the absence of retinal ganglion cells, suggested that cholinergic amacrine cells could provide a scaffold for the subsequent in-growth of bipolar cell axons. To test this hypothesis directly, a new cholinergic cell immunotoxin was constructed by conjugating saporin, the ribosome-inactivating protein toxin, to an antibody against the vesicular acetylcholine transporter. A single intraocular injection of the immunotoxin caused a rapid, complete, and selective loss of cholinergic amacrine cells from the developing rat retina. On and Off cone bipolar cells were visualized using an antibody against recoverin, the calcium-binding protein that labels the soma and processes of these interneurons. After complete depletion of cholinergic amacrine cells, cone bipolar cell axon terminals still formed their two characteristic strata within the IPL. These findings demonstrate that the presence of cholinergic amacrine cells is not required for the segregation of recoverin-positive On and Off cone bipolar cell projections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896166      PMCID: PMC6758270     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

1.  Morphological differentiation of bipolar cells in the ferret retina.

Authors:  E D Miller; M N Tran; G K Wong; D M Oakley; R O Wong
Journal:  Vis Neurosci       Date:  1999 Nov-Dec       Impact factor: 3.241

2.  Requirement for cholinergic synaptic transmission in the propagation of spontaneous retinal waves.

Authors:  M B Feller; D P Wellis; D Stellwagen; F S Werblin; C J Shatz
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

3.  Effects of neonatal lesions of the basal forebrain cholinergic system by 192 immunoglobulin G-saporin: biochemical, behavioural and morphological characterization.

Authors:  G Leanza; O G Nilsson; G Nikkhah; R G Wiley; A Björklund
Journal:  Neuroscience       Date:  1996-09       Impact factor: 3.590

Review 4.  Pathways to regulated exocytosis in neurons.

Authors:  P De Camilli; R Jahn
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

5.  Structural basis for ON-and OFF-center responses in retinal ganglion cells.

Authors:  E V Famiglietti; H Kolb
Journal:  Science       Date:  1976-10-08       Impact factor: 47.728

6.  Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.

Authors:  P A Davol; A Bizuneh; A R Frackelton
Journal:  Anticancer Res       Date:  1999 May-Jun       Impact factor: 2.480

Review 7.  Extracellular matrix in early cortical development.

Authors:  A L Pearlman; A M Sheppard
Journal:  Prog Brain Res       Date:  1996       Impact factor: 2.453

8.  Molecular cloning of a putative vesicular transporter for acetylcholine.

Authors:  A Roghani; J Feldman; S A Kohan; A Shirzadi; C B Gundersen; N Brecha; R H Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.

Authors:  R J Youle; D M Neville
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

10.  Localization of mRNAs for trkB isoforms and p75 in rat retinal ganglion cells.

Authors:  A Suzuki; S Nomura; E Morii; Y Fukuda; J Kosaka
Journal:  J Neurosci Res       Date:  1998-10-01       Impact factor: 4.164

View more
  7 in total

1.  Expression of the LIM-homeodomain protein Isl1 in the developing and mature mouse retina.

Authors:  Yasser Elshatory; Min Deng; Xiaoling Xie; Lin Gan
Journal:  J Comp Neurol       Date:  2007-07-01       Impact factor: 3.215

2.  Developmental mechanisms that regulate retinal ganglion cell dendritic morphology.

Authors:  Ning Tian
Journal:  Dev Neurobiol       Date:  2011-12       Impact factor: 3.964

Review 3.  Assembly and disassembly of a retinal cholinergic network.

Authors:  Kevin J Ford; Marla B Feller
Journal:  Vis Neurosci       Date:  2011-07-26       Impact factor: 3.241

4.  Sulforaphane protects rodent retinas against ischemia-reperfusion injury through the activation of the Nrf2/HO-1 antioxidant pathway.

Authors:  Hong Pan; Meihua He; Ruixing Liu; Nicholas C Brecha; Albert Cheung Hoi Yu; Mingliang Pu
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

5.  Cholinergic neural activity directs retinal layer-specific angiogenesis and blood retinal barrier formation.

Authors:  G A Weiner; S H Shah; C M Angelopoulos; A B Bartakova; R S Pulido; A Murphy; E Nudleman; R Daneman; J L Goldberg
Journal:  Nat Commun       Date:  2019-06-06       Impact factor: 14.919

6.  Recruitment of the rod pathway by cones in the absence of rods.

Authors:  Enrica Strettoi; Alan J Mears; Anand Swaroop
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

7.  Targeted destruction of photosensitive retinal ganglion cells with a saporin conjugate alters the effects of light on mouse circadian rhythms.

Authors:  Didem Göz; Keith Studholme; Douglas A Lappi; Mark D Rollag; Ignacio Provencio; Lawrence P Morin
Journal:  PLoS One       Date:  2008-09-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.